Hope for aggressive breast cancer. Survivors and doctors discuss breakthroughs, fears, and the need for inclusive research.

Her skin hypopigmentation (discoloration of the skin) began as a minor issue in 2022 while taking a different treatment, Lenvima with Keytruda ... are hair color change and skin hypopigmentation.

As digital channels become the backbone for sharing information and facilitating school-to-home connections, Edlio, a leading provider of technology ...

Minutes later, after being pressed about Q4 infusion numbers, Mr. Vogt provided some color: “95 revenue infusions ... Amtagvi in combination with Keytruda in frontline melanoma, which ...

Summit Therapeutics' ivonescimab shows strong efficacy in trials, with Cantor Fitzgerald predicting a 50% market share in the ...

For patients with unresectable, non-metastatic hepatocellular carcinoma, Lenvima plus Keytruda in combination with TACE improved outcomes. Among patients with unresectable, non-metastatic ...

Merck is bracing for the years of sales growth from oncology superstar Keytruda to take a sharp turn in 2028—and for more reasons than one. Along with a key U.S. patent expiring at the end of ...

Merck (NYSE:MRK) said it expects its top-selling drug, Keytruda, to be selected by the U.S. government for price setting negotiations next year under the Inflation Reduction Act. In a filing with ...

Keytruda's sBLA for LA-HNSCC treatment is under FDA priority review, with a decision expected by June 23. The KEYNOTE-689 trial showed significant improvements in event-free survival and major ...

Severance’s use of color is not only highly intentional, it’s helpful in understanding characters’ intentions, allegiances, and behavior. For a show layered in puzzles and hidden meaning ...